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Abstract
Background: Salmonella Typhi causes an estimated 21 million new cases of typhoid fever and 216,000 deaths every 
year. Blood culture is currently the gold standard for diagnosis of typhoid fever, but it is time-consuming and takes 
several days for isolation and identification of causative organisms. It is then too late to initiate proper antibiotic 
therapy. Serological tests have very low sensitivity and specificity, and no practical value in endemic areas. As early 
diagnosis of the disease and prompt treatment are essential for optimal management, especially in children, a rapid 
sensitive detection method for typhoid fever is urgently needed. Although PCR is sensitive and rapid, initial research 
indicated similar sensitivity to blood culture and lower specificity. We developed a fast and highly sensitive blood 
culture PCR method for detection of Salmonella Typhi, allowing same-day initiation of treatment after accurate 
diagnosis of typhoid.
Methods: An ox bile tryptone soy broth was optimized for blood culture, which allows the complete lysis of blood cells 
to release intracellular bacteria without inhibiting the growth of Salmonella Typhi. Using the optimised broth 
Salmonella Typhi bacteria in artificial blood samples were enriched in blood culture and then detected by a PCR 
targeting the fliC-d gene of Salmonella Typhi.
Results: Tests demonstrated that 2.4% ox bile in blood culture not only lyzes blood cells completely within 1.5 hours so 
that the intracellular bacteria could be released, but also has no inhibiting effect on the growth of Salmonella Typhi.
Three hour enrichment of Salmonella Typhi in tryptone soya broth containing 2.4% ox bile could increase the
bacterial number from 0.75 CFU per millilitre of blood which is similar to clinical typhoid samples to the level which
regular PCR can detect. The whole blood culture PCR assay takes less than 8 hours to complete rather than several
days for conventional blood culture.
Conclusions: This novel blood culture PCR method is superior in speed and sensitivity to both conventional blood 
culture and PCR assays. Its use in clinical diagnosis may allow early detection of the causative organism and facilitate 
initiation of prompt treatment among patients with typhoid fever.
Introduction
Salmonella enterica serovar Typhi, the human-specific,
causative agent of typhoid fever, causes an estimated 21
million new cases and 216,000 deaths every year [1]. It is
generally thought that Salmonella enterica serovar Typhi,
an enterically acquired invasive pathogen, penetrates the
ileal epithelium and is transported via underlying mac-
rophages to spleen, liver, and other target tissues during
the normal disease course. Natural clearance of the dis-
ease is thought to entail development of specific humoral
and cellular immune responses. However, the precise
mechanisms of Salmonella serovar Typhi virulence and
immune protection are not well understood, mainly due
to the absence of a suitable animal model. We have been
developing a human typhoid challenge model which
could increase understanding of the pathogenesis of
typhoid fever, the immunobiology of the disease and the
correlates of protection, and provide a model for evalua-
tion of new vaccines. In the case of Salmonella serovar
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Page 2 of 7Typhi, there is an urgent need for new improved vaccines,
as those currently available all have limitations. In the
planned clinical typhoid challenge study the volunteers
will receive oral inoculation with wild-type Salmonella
serovar Typhi, followed by monitoring for 14 days to
detect the presence and load of Salmonella serovar Typhi
in blood, which requires a robust, rapid and sensitive
method of detection of Salmonella serovar Typhi.
Currently there is lack of reliable, rapid and sensitive
methods for the clinical detection Salmonella serovar
Typhi. In the regions where enteric fever is common, clin-
ical diagnosis of typhoid fever is inadequate, as the symp-
toms it causes are non-specific and overlap with those of
other febrile illness, such as vector-borne malaria, dengue
fever and rickettsioses as well as environmentally trans-
mitted leptospirosis and melioidosis [2,3]. Serological
tests, predominantly the Widal test, are available but have
very low sensitivity and specificity, and no practical value
in endemic areas despite their continued use [4]. Isolation
of the causative organism remains the most effective
diagnostic method in suspected typhoid fever and blood
has been the main sample for culture for Salmonella sero-
var Typhi since 1900 [5,6]. The sensitivity of blood cul-
ture is highest in the first week of the illness and reduces
with advancing illness [7]. However, blood culture is
time-consuming and takes at least 2 to 5 days until the
identification of the organism. Blood culture can identify
45 to 70% of patients with typhoid fever, depending on
the amount of blood sampled, the bacteraemic level of
Salmonella serovar Typhi, the type of culture medium
used, and the length of incubation period [8,9]. Several
factors may contribute to failure to isolate the organism
from blood, including inadequate laboratory media,
intrinsic bactericidal activity of blood, the volume of
blood taken for culture, the presence of antibiotics and
the time of blood collection. The intracellular nature of
Salmonella serovar Typhi also slows its growth in blood
culture media. One study found that more than 50% of
bacterial cells were present intracellularly in the blood
from patients with typhoid fever [8]. In the first review of
blood culture in typhoid fever in 1907 Coleman recom-
mended the use of ox bile broth [10]. Its superior qualities
were attributed to the inhibition of bactericidal activity of
blood and its ability to release intracellular bacteria [11].
Given the problems associated with the diagnosis of
typhoid fever by blood culture and serological methods,
PCR methods were recently exploited. Several studies
have been reported since the first evaluation of PCR as a
diagnostic tool for typhoid fever in 1993 when Song et al.
successfully amplified the flagellin gene (fliC-d) of Salmo-
nella serovar Typhi in all cases of culture proven typhoid
fever and from none of the healthy controls [12-18].
These studies reported excellent sensitivity and specific-
ity when compared to positive (blood culture proven) and
healthy controls. The clinical utility of these PCR tests
was inadequately evaluated though some studies claimed
that as few as 10 bacteria per millilitre of blood could be
detected. The number of Salmonella bacteria circulating
in the blood of a patient with Salmonella bacteremia is
small. One study found 0.5-22 bacteria per millilitre of
blood in 15 patients with typhoid fever [19], and another
showed a median of 0.3 (IQR, 0.1-10) bacteria per millil-
itre of blood from 81 patients with typhoid fever [8]. The
very low ratio of bacterial to human DNA means that the
PCR template in clinical preparations is dominated by
mammalian DNA and could cause false-positive PCR sig-
nals due to the non-specific binding of primers and false-
negative results due to reduced sensitivity. In practice, the
large excess of human DNA does indeed cause problems
for PCR-based pathogen detection in blood, particularly
in samples with low bacterial numbers [20,21]. Further-
more, small volumes of blood are often used for DNA
extraction or as template in the PCR, which will signifi-
cantly lower the sensitivity of these tests.
In the present study, we describe a fast and highly sensi-
tive blood culture PCR method for detection of Salmo-
nella serovar Typhi. The method uses the optimised ox
bile-containing medium in blood culture for enrichment
of bacteria, combined with a PCR assay, to reduce turn-




Wild-type Salmonella serovar Typhi Quailes strain was
obtained from the University of Maryland through Cen-
tres for Disease Control and Prevention, Atlanta, USA.
The strain was originally isolated from a carrier in 1958,
and was previously used as a challenge strain over 20
years (in the 1960s and 1970s) during which almost 2000
volunteers ingested the strain as participants in vaccine
efficacy and pathogenesis studies. The strain was last
stored in 1988 and was maintained frozen until shipping
to Oxford in 2008. In this study the strain was sub-cul-
tured in tryptone soya broth (TSB) or on tryptone soya
agar (TSA) (Oxoid, Basingstoke, UK) as needed.
Preparation of Salmonella serovar Typhi Quailes strain 
inocula
Salmonella serovar Typhi Quailes strain was cultured on
TSA plate for 16 hours at 37°C, and collected in TSB
medium. The culture was first adjusted to an optical den-
sity at 600 nm of 0.25 and then prepared for serial 10-fold
dilutions in TSB. The number of Salmonella bacteria per
millilitre was determined by plating each dilution onto
TSA plates. Colonies were counted after incubation of
the plates overnight at 37°C.
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bile medium
About 2-6 colony-forming-unit (CFU) of Salmonella
serovar Typhi Quailes strain in 0.1 ml TSB was inoculated
into 20 ml TSB each containing 0, 1.2, 1.6, 2.0, 2.4, 4.0 and
10.0% (w/v) of ox bile (Oxgall, BD Biosciences, Oxford,
UK). The culture was shaken at 200 revolutions per min-
ute (RPM) at 37°C in an incubator for 5 hours, and then
centrifuged at 6,000 × g for 20 min. The pellet was re-sus-
pended in 0.5 ml TSB and plated onto TSA plates. The
plates were incubated overnight at 37°C and colonies
were counted.
Lysis of blood cells in TSB-bile medium
Blood was removed from healthy individuals with a ster-
ile syringe and immediately pipetted into tubes contain-
ing heparin. 1 ml of blood was mixed with 4 ml of TSB
each containing 0, 1.5, 2.0, 2.5, 3.0 and 5.0% (w/v) of ox
bile, giving final concentrations 0, 1.2, 1.6, 2.0, 2.4 and
4.0% (w/v) of ox bile and 20% (v/v) of blood. The mixture
was gently shaken for up to 5 hours at room temperature.
10 μl samples were taken periodically and mixed with 200
μl phosphate buffered saline (PBS). The lysis of blood
cells was examined by microscopy.
TSB-bile blood culture of Salmonella serovar Typhi Quailes 
strain
For blood culture of Salmonella serovar Typhi Quailes
strain, 4 ml blood was spiked with 2-6 CFU of Salmonella
serovar Typhi, and then mixed with 16 ml TSB containing
3.0% (w/v) ox bile in a 50 ml tube, giving a final concen-
tration of ox bile at 2.4% (w/v) and blood at 20% (v/v).
The culture was shaken at 200 RPM at 37°C in an incuba-
tor for up to 5 hours. Two tubes were removed from the
incubator every hour and the cells were collected by cen-
trifugation at 6,000 × g for 20 min. The supernatant was
discarded and the pellet was re-suspended in 0.5 ml TSB.
One tube was plated onto TSA plates for determination
of the number of CFU in each sample and another tube
was used for DNA extraction.
DNA extraction
DNA was isolated from the culture using UltraClean™
BloodSpin™ Kit (MO BIO Laboratories, CA, USA)
according to the manufacturer's instruction, except that
the DNA was eluted with 100 μl Buffer 5 and incubated at
65°C for 5 min before centrifugation. The aliquots of
DNA preparation were separated by electrophoresis on
1% agarose gels, stained with ethidium bromide, and pho-
tographed by a UV transilluminator. The quantity and
quality of the DNA preparations were compared.
PCR Primers of Salmonella serovar Typhi Quailes strain
The PCR primers for Salmonella serovar Typhi Quailes
strain were designed according to the fliC-d gene
sequence of Salmonella serovar Typhi (Accession num-
ber L21912): H-for (ACTCAGGCTTCCCGTAACGC)
and Hd-rev (GGCTAGTATTGTCCTTATCGG) [22],
and synthesized by Sigma Genosys (Sigma-Aldrich, Dor-
set, England).
PCR protocol
The PCR reaction was carried out in a 50 μl volume, com-
prising 0.5 U of Taq DNA polymerase (Qiagen, Crawley,
UK), 1 × Qiagen PCR buffer, 1.5 mM magnesium chlo-
ride, 200 μM concentrations of each deoxynucleoside
triphosphate, 0.5 μM concentrations of the primers H-for
and Hd-rev, and 10 μl of DNA template. The following
amplification steps were used: 1 cycle of 95°C for 5 min;
35 cycles of 93°C for 30 sec, 55°C for 30 sec, and 72°C for
40 sec; and 1 cycle of 72°C for 5 min. The PCR amplifica-
tion product was separated by electrophoresis on a 1%
agarose gel, stained with ethidium bromide, and photo-
graphed by a UV transilluminator.
Results
Effect of ox bile on the growth of Salmonella serovar Typhi 
Quailes strain
The growth of Salmonella serovar Typhi Quailes strain in
20 ml TSB containing different concentrations of ox bile
inoculated with four CFU is shown in Figure 1. There was
no difference in the growth of Salmonella serovar Typhi
Quailes strain in TSB with bile concentrations between 0
and 2.0%. At a bile concentration of 2.4%, the growth of
Salmonella serovar Typhi Quailes strain became slower
than those at the lower bile concentrations. However,
4.0% bile reduced the growth of Salmonella serovar Typhi
Quailes strain by more than 50%, and eventually Salmo-
nella serovar Typhi Quailes strain stopped growing when
the bile concentration reached 10.0%.
Effect of ox bile on blood cells
Bile rapidly and completely lyzed blood cells (see Table 1).
No lysis of blood cells was found in TSB, and only partial
lysis at a bile concentration of 1.2%, even after incubation
for up to 5 hours. However, the blood cells were com-
pletely lyzed within 3 hours at a bile concentration of
1.6% and above. The higher the bile concentration, the
faster the lysis of blood cells.
Growth and PCR detection of Salmonella serovar Typhi 
Quailes strain in TSB-bile blood culture system
Based on the effect of bile on the growth of Salmonella
serovar Typhi Quailes strain and the observation that bile
did lyze blood cells, a TSB-bile blood culture system con-
taining 2.4% ox bile and 20% blood was selected for Sal-
monella serovar Typhi Quailes strain blood culture. Table
2 shows the effect on CFU counts and PCR detection of
Salmonella serovar Typhi Quailes strain using the TSB-
bile blood culture system. The culture started from 3
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incubation in this culture system. In the first hour the
bacteria did not multiply, but the growth gradually picked
up from the second hour. The number of CFU increased
from 3 to 105 within 3 hours and rose more than thou-
sand times during 5 hours of incubation. When the DNA,
prepared periodically from the cultures, was used as PCR
template, the amplicons of fliC-d gene of Salmonella
serovar Typhi Quailes strain were seen, as shown in Fig-
ure 2. Three independent experiments found that the
fliC-d gene of Salmonella serovar Typhi in the DNA
preparations made from the cultures after 3 to 5 hours of
incubation was detected by PCR, but not in those made
from the cultures incubated for less than 3 hours (see
Figure 1 The growth of Salmonella serovar Typhi Quailes strain in TSB containing different concentrations of ox bile. Four bacteria were in-
cubated in 20 ml TSB containing different concentrations of bile at 37°C for 5 hours. The CFU was the mean of three independent cultures.
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DNA preparations made from the cultures was used in
each PCR reaction, and the fliC-d amplicons were only
seen in the cultures with more than 105 CFU of Salmo-
nella serovar Typhi shown in Table 2, the limit of detec-
tion for this assay was about 10 CFU per PCR reaction.
This study used a 4 ml blood sample spiked with 3 CFU of
Salmonella serovar Typhi Quailes strain for the culture,
and therefore the sensitivity of this blood culture-PCR
method was equivalent to 0.75 CFU per millilitre of
blood. At least three hours of incubation were needed for
the bacteria to be enriched to a detectable level with a
regular PCR.
Discussion
Blood culture is currently the gold standard for diagnosis
of typhoid fever, but it takes several days for the isolation
and identification of causative organisms. As early diag-
nosis of the disease and prompt treatment are essential
for optimal management, especially in children, a rapid
sensitive detection method for typhoid fever is urgently
needed. PCR is sensitive and rapid, and could possibly
replace blood culture as the new "gold standard". How-
ever, initial research indicated similar sensitivity to blood
culture and lower specificity [23].
Given the problems associated with conventional
methods for diagnosis of typhoid fever, the present study
was carried out in an attempt to develop a rapid, reliable,
specific, and sensitive method for detection of Salmo-
nella serovar Typhi. Artificially spiked blood samples
were used throughout the study to mimic clinical speci-
mens in the development and evaluation of a blood cul-
ture PCR method for detection of Salmonella serovar
Typhi.
Early studies found that the number of Salmonella bac-
teria circulating in the blood of patients with Salmonella
bacteremia is small, e.g. 0.5-22 bacteria per millilitre of
blood found in 15 patients with typhoid fever [19], fewer
than 2 bacteria per millilitre of blood found in 90% of 80
positive blood cultures from patients with Salmonella
bacteremia [11], and a median of 0.3 (IQR, 0.1-10) bacte-
ria per millilitre of blood in further 81 patients with
typhoid fever [8]. Therefore, it is very important to use
small bacterial inocula when developing and evaluating a
system for detection of Salmonella serovar Typhi in clini-
cal specimens. In the present study, blood samples were
spiked with Salmonella serovar Typhi Quailes strain at a
ratio of 1 ± 0.5 CFU per millilitre of blood, which closely
mimics clinical specimens taken from patients with
typhoid fever.
The initial evaluation study, in which 2-6 CFU of Sal-
monella serovar Typhi Quailes strain were mixed with 4
ml of blood and then cultured in TSB medium, found that
the bacteria did not grow during 5 hours of incubation.
The results remained the same when blood samples taken
from different healthy donors were used. Moreover, when
blood was artificially inoculated with a small number of
Salmonella bacteria, followed by plating, fewer bacteria
were recovered from the inoculated blood samples than
the input (data not shown). This, consistent with other
studies [11,19,24,25], clearly demonstrates that human
blood has bactericidal activity against Salmonella serovar
Typhi. Furthermore, one study found that the defibri-
nated whole blood from patients with Salmonella bacter-
emia was bactericidal for small inocula of three of five
Salmonella strains isolated from the patient's blood [24].
This suggests that the blood or serum of patients with
Salmonella bacteremia is also frequently bactericidal
against the Salmonella isolated from their blood. There-
fore, a culture medium which inhibits the bactericidal
activity of blood may be beneficial in the development of
a blood culture-PCR assay system.
Figure 2 Salmonella serovar Typhi fliC-d amplicons (763 bp) on a 
1% agarose gel. Lanes: M, DNA marker; 1, 5 hour culture; 2, 4 hour cul-
ture; 3, 3 hour culture, 4, 2 hour culture; 5, 1 hour culture; 6, 0 hour cul-
ture; 7, No DNA template negative control; N, 5 hour blood culture 
control without bacteria; P, Salmonella serovar Typhi DNA positive con-
trol.
Table 2: The growth and PCR detection of Salmonella 
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*Three bacteria of Salmonella serovar Typhi were incubated in the 
TSB-bile blood culture containing 2.4% ox bile and 20% blood. a 
The mean of three independent experiments; b Salmonella 
serovar Typhi fliC-d amplicons resulting from PCR using the DNA 
templates prepared from three independent cultures.
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with Salmonella bacteremia in 1906 [26], bile containing
media have repeatedly been found superior for isolation
of enteric fever pathogens (Salmonella serovars, Typhi
and Paratyphi) from whole blood [11]. Conradi attributed
the effectiveness of bile as a culture medium to its effect
in preventing coagulation of blood [26], and further dem-
onstrated that bile decreases the bactericidal activity of
serum [27]. Although Kaye et al. did not find that the
anticoagulant effect was an important factor in the supe-
riority of bile over TSB as a blood culture medium for
Salmonella, they confirmed and expanded the observa-
tion that bile decreases the bactericidal activity of serum
[11]. They found that bile inactivated the complement
activity of blood, and also disrupted leukocytes in which
Salmonella may be present. They argued that in patients
with Salmonella bacteremia rapid release of Salmonella
from leukocytes by bile might be a very important factor
contributing to the advantage of bile as a culture medium.
The intracellular presence of Salmonella serovar Typhi
was demonstrated by the study [8] showing that the num-
ber of CFU of Salmonella serovar Typhi per milillitre
sample increased by 3.3 fold and 1.9 fold respectively
when bone marrow and blood cells were lyzed. There-
fore, a blood culture medium could increase bacterial
growth if it contains blood cell lyzing agents. Having
examined further the effect of bile on the growth of Sal-
monella serovar Typhi, the present study confirmed the
observation that bile does not have a growth-promoting
effect on Salmonella [11]. In fact, Salmonella serovar
Typhi Quailes strain did not survive in 10% bile in the
absence of TSB (data not shown). Furthermore, the pres-
ent study also demonstrated that bile, in absence of
blood, inhibits the growth of Salmonella serovar Typhi
Quailes strain at high concentrations of bile in TSB-bile
medium. In order to determine the concentration of bile
for use in a TSB-bile blood culture system, the lysis of
blood cells by bile was studied. The results showed that
the lysis of blood cells depends on the bile concentration
and incubation time. At a concentration of 2.4%, bile not
only lyzes blood cells completely within 1.5 hours so that
the intracellular bacteria could be released, but also has
no inhibiting effect on the growth of Salmonella serovar
Typhi Quailes strain. Therefore, 2.4% bile seems an opti-
mal concentration for use in the TSB-bile blood culture
system.
It has been asserted that PCR is sensitive and rapid, and
is a better alternative than conventional methods for
pathogen detection. In the last decade, PCR has been
widely researched for early diagnosis of typhoid fever.
PCR as a diagnostic tool for detection of Salmonella sero-
var Typhi was first studied by Song et al. [12] who devel-
oped a nested PCR for amplification of the fliC-d gene of
Salmonella serovar Typhi which could detect 5 bacteria/
ml, compared to106 bacteria/ml by regular PCR. Recently,
Ali et al. [18] reported a nested multiplex PCR for detec-
tion of both Salmonella serovars, Typhi and Paratyphi,
with a sensitivity of 10 bacteria/ml. However, initial
research indicated that PCR has similar sensitivity to
blood culture and lower specificity [23]. This, at least in
part, can be attributed to the low number of Salmonella
bacteria circulating in the blood of typhoid patients and
the inadequate method of DNA preparation. In normal
clinical samples, there is a median of 0.3 CFU per millil-
itre of blood which is far below the sensitivity of PCR so
far developed, and therefore, it is not surprising that PCR
has not been used for diagnosis of typhoid fever. To over-
come the difficulties caused by the low numbers of Sal-
monella bacteria present in typhoid patient blood
samples, pre-enrichment of bacteria is necessary prior to
PCR detection. A recent study demonstrated that the 5
hour broth culture enrichment improved PCR sensitivity
by 10 times for spiked blood, and 100 times for spiked
stool samples [28]. The present study has used the opti-
mized TSB-bile blood culture system, in which 0.75 bac-
teria per ml of blood was used to mimic real clinical
samples, and 4 ml blood for the culture with 3 CFU in
total, for enrichment of bacteria prior to the PCR detec-
tion of Salmonella serovar Typhi. At the bacterial level
used in present study, it was very difficult to detect the
presence of Salmonella serovar Typhi by regular PCR
without bacterial enrichment and/or removal of human
DNA. However, three hour enrichment of Salmonella
serovar Typhi in the TSB-bile medium could increase the
number of CFUs to the level at which detection is possi-
ble using regular PCR. The sensitivity of this novel blood
culture PCR method was equivalent to 0.75 CFU per mil-
lilitre of blood which is comparable to the bacterial num-
ber present in clinical typhoid samples. Moreover, the
turnaround time of the assay was less than 8 hours rather
than several days for conventional blood culture. There-
fore, this new TSB-bile blood culture PCR system is supe-
rior (speed and sensitivity) to conventional blood culture
and PCR methods and could potentially make early
detection of Salmonella serovar Typhi possible for
prompt treatment of patients with typhoid fever.
Competing interests
AJP acts as chief and principal investigator for clinical trials conducted on
behalf of Oxford University, sponsored by vaccine manufacturers (Novartis Vac-
cines, GlaxoSmithKline, Sanofi-Pasteur, Sanofi-Pasteur MSD, and Wyeth Vac-
cines), but does not receive any personal payment from them. Industry
sourced honoraria for consultancy, lecturing or writing and travel expenses
and grants for educational activities are paid directly to an educational/admin-
istrative fund held by the Department of Paediatrics, University of Oxford or an
independent charity.
Authors' contributions
LZ and AJP conceived of the study and carried out its design. LZ performed the
assays and drafted the manuscript. AJP edited the manuscript. All authors read
and approved the final manuscript.
Zhou and Pollard Annals of Clinical Microbiology and Antimicrobials 2010,
9:14
Page 7 of 7Acknowledgements
This work was supported by the Oxford Partnership Comprehensive Biomedi-
cal Research Centre Programme with funding from the Department of Health's 
NIHR Biomedical Research Centres funding scheme. AJP is a Jenner Institute 
Investigator. Wild-type Salmonella serovar Typhi Quailes strain was provided by 
University of Maryland.
Author Details
Oxford Vaccine Centre, University of Oxford, Oxford, UK
References
1. Crump JA, Luby SP, Mintz ED: The global burden of typhoid fever.  Bull 
World Health Organ 2004, 82:346-353.
2. Petit PL, Wamola IA: Typhoid fever: a review of its impact and diagnostic 
problems.  East Afr Med J 1994, 71:183-188.
3. Stuart BM, Pullen RL: Typhoid fever: clinical analysis of three hundred 
and sixty cases.  Arch Intern Med 1946, 78:629-661.
4. Levine MM, Grados O, Gilman RH, Woodward WE, Solis-Plaza R, Waldman 
W: Diagnostic value of the Widal test in areas endemic for typhoid 
fever.  Am J Trop Med Hyg 1978, 27(4):795-800.
5. Parry CM, Hien TT, Dougan G, White NJ, Farrar JJ: Typhoid fever.  N Engl J 
Med 2002, 347(22):1770-1782.
6. Wain J, Hosoglu S: The laboratory diagnosis of enteric fever.  J Infect 
Developing Countries 2008, 2(6):421-425.
7. Kundu R, Ganguly N, Ghosh TK, Yewale VN, Shah RC, Shah NK: IAP Task 
Force Report: diagnosis of enteric fever in children.  Indian Pediatr 2006, 
43(10):875-883.
8. Wain J, Pham VB, Ha V, Nguyen NM, To SD, Walsh AL, Parry CM, Hasserjian 
RP, HoHo VA, Tran TH, Farrar J, White NJ, Day NP: Quantitation of bacteria 
in bone marrow from patients with typhoid fever: relationship 
between counts and clinical features.  J Clin Microbiol 2001, 
39(4):1571-1576.
9. Wain J, To SD, Phan VB, Walsh AL, Ha V, Nguyen MD, Vo AH, Tran TH, Farrar 
J, White NJ, Parry CM, Day NP: Specimens and culture media for the 
laboratory diagnosis of typhoid fever.  J Infect Developing Countries 2008, 
2(6):469-474.
10. Coleman W, Buxton BH: The bacteriology of the blood in typhoid fever.  
Amer J Med Sci 1907, 133:896-903.
11. Kaye D, Palmieri M, Rocha H: Effect of bile on the action of blood against 
Salmonella.  J Bacteriol 1966, 91(3):945-952.
12. Song JH, Cho H, Park MY, Na DS, Moon HB, Pai CH: Detection of 
Salmonella typhi in the blood of patients with typhoid fever by 
polymerase chain reaction.  J Clin Microbiol 1993, 31:1439-1443.
13. Haque A, Ahmed N, Peerzada A, Raza A, Bashir S, Abbas G: Utility of PCR in 
diagnosis of problematic cases of typhoid.  Jpn J Infect Dis 2001, 
54:237-239.
14. Kumar A, Arora V, Bashamboo A, Ali S: Detection of Salmonella typhi by 
polymerase chain reaction: implications in diagnosis of typhoid fever.  
Infect Genet Evol 2002, 2:107-110.
15. Massi MN, Shirakawa T, Gotoh A, Bishnu A, Hatta M, Kawabata M: Rapid 
diagnosis of typhoid fever by PCR assay using one pair of primers from 
flagellin gene of Salmonella typhi.  J Infect Chemother 2003, 9:233-237.
16. Prakash P, Mishra OP, Singh AK, Gulati AK, Nath G: Evaluation of nested 
PCR in diagnosis of typhoid fever.  J Clin Microbiol 2005, 43:431-432.
17. Hatta M, Smits HL: Detection of Salmonella typhi by nested polymerase 
chain reaction in blood, urine, and stool samples.  Am J Trop Med Hyg 
2007, 76(1):139-143.
18. Ali A, Haque A, Haque A, Sarwar Y, Mohsin M, Bashir S, Tariq A: Multiplex 
PCR for differential diagnosis of emerging typhoidal pathogens 
directly from blood samples.  Epidemiol Infect 2009, 137:102-107.
19. Watson KC: Isolation of Salmonella typhi from the blood stream.  J Lab 
Clin Med 1955, 46:128-134.
20. Horz HP, Scheer S, Huenger F, Vianna ME, Conrads G: Selective isolation 
of bacterial DNA from human clinical specimens.  J Microbiol Methods 
2008, 72(1):98-102.
21. Handschur M, Karlic H, Hertel C, Pfeilstöcker M, Haslberger AG: Preanalytic 
removal of human DNA eliminates false signals in general 16S rDNA 
PCR monitoring of bacterial pathogens in blood.  Comp Immunol 
Microbiol Infect Dis 2009, 32(3):207-219.
22. Levy H, Diallo S, Tennant SM, Livio S, Sow SO, Tapia M, Fields PI, Mikoleit M, 
Tamboura B, Kotloff KL, Lagos R, Nataro JP, Galen JE, Levine MM: PCR 
method to identify Salmonella enterica serovars Typhi, Paratyphi A, 
and Paratyphi B among Salmonella Isolates from the blood of patients 
with clinical enteric fever.  J Clin Microbiol 2008, 46(5):1861-1866.
23. Bhutta ZA: Current concepts in the diagnosis and treatment of typhoid 
fever.  BMJ 2006, 333(7558):78-82.
24. Khairat O: The bactericidal power of theblood for the infecting 
organism in bacteriaemia.  J Pathol Bacteriol 1946, 58:359-365.
25. Mackie TJ, Finkelstein MH: Natural bactericidal antibodies: 
observationson the bactericidal mechanism of normalserum.  J Hyg 
1931, 31:35-55.
26. Conradi H: Ein Verfahren zum Nachweis der Typhuserreger im Blut.  
Deut Med Wochschr 1906, 32:58-61.
27. Conradi H: Ueber das Verhalten der imBlute der Typhuskranken 
nachweisbaren Typhusbazillen gegenuber der bakterizidenWirkung 
des Blutes.  Muench Med Wochschr 1906, 53:1361.
28. Teh CS, Chua KH, Puthucheary SD, Thong KL: Further evaluation of a 
multiplex PCR for differentiation of Salmonella paratyphi A from other 
salmonellae.  Jpn J Infect Dis 2008, 61(4):313-314.
doi: 10.1186/1476-0711-9-14
Cite this article as: Zhou and Pollard, A fast and highly sensitive blood cul-
ture PCR method for clinical detection of Salmonella enterica serovar Typhi 
Annals of Clinical Microbiology and Antimicrobials 2010, 9:14
Received: 20 January 2010 Accepted: 19 April 2010 
Published: 19 April 2010
This article is available from: http://www.ann-clinmicrob.com/content/9/1/14© 2010 Zhou nd Po lard; licensee BioMed Central Ltd. is an Open Access articl  distributed u der the erms f the Cr ative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.Annals of Cl nical Microbi logy and An imicrobials 2010, 9:14
